01—Abstract
Summary
Summary of the 10-K filed March 28, 2003. Cited figures are marked; the original filing is the authoritative source.
Intuitive Surgical's 2002 10-K shows a company still in early commercialization of the da Vinci Surgical System.
Sales rose 39% to $72.0 milliona on 60 system sales (vs. 49 in 2001), with average selling price rising to $948,000. Gross margin improved to 52% from 45%, and recurring instrument, accessory and service revenue grew to 21% of sales. Despite this progress, the company still lost $18.4 million for the year, cash and short-term investments fell to $50.8 million, and cumulative system placements reached 149.
The dominant investor issue is the pending merger with Computer Motion, announced March 7, 2003. Intuitive expects to issue about 14.7 million shares, leaving current holders with roughly 72% and former Computer Motion holders with about 28%, and it projects $18 millionb in annual pre-tax cost savings. The deal also resolves a long-running patent war: the litigation is stayed through August 31, 2003 and would be dismissed if the merger closes.
Intuitive has also extended a $7.3 millionc bridge loan to Computer Motion. Combined cash is projected below $35 million, so funding and dilution are central considerations.
Key risks include unresolved patent litigation (notably the Computer Motion and Brookhill-Wilk suits, which could bar product sales if lost), ongoing losses, dependence on a high-price capital product with lengthy sales cycles, and limited history of profitability. The company says current resources should suffice through 2003, with additional financing possibly needed thereafter.
02—Key points
Key Highlights
- Revenue grew 39% to $72.0M in 2002, driven by 60 system sales (up from 49) and a higher ASP of $948K
- Gross margin expanded to 52% from 45% in 2001 on higher ASPs and manufacturing efficiencies
- Recurring instrument, accessory and service revenue rose to 21% of sales from 14% in 2001, with recurring revenue up 116% to $15.1M
- Net loss narrowed slightly to $18.4M from $16.7M in 2001 (loss widened, so operating loss held roughly flat at $20.2M); cumulative placements reached 149 systems
- Pending merger with Computer Motion: ~14.7M new shares issued, ~72%/28% ownership split, and ~$18M projected annual pre-tax cost savings
- Cash and short-term investments declined to $50.8M; combined post-merger cash projected below $35M
- Patent litigation with Computer Motion and Brookhill-Wilk remains a material risk; the Computer Motion suit is stayed through August 31, 2003 pending the merger
03—Questions
Frequently Asked Questions
Why is Intuitive Surgical acquiring Computer Motion, and what does the merger mean for shareholders?
The companies say the merger combines complementary technologies and intellectual property, ends costly patent litigation, and enables about $18 million in annual pre-tax cost savings, largely through headcount reductions. Current Intuitive holders would own about 72% of the combined company, so their share of future earnings and value is diluted by the roughly 28% going to former Computer Motion holders. The merger requires approval from both companies' stockholders, with a meeting expected around June 2003.
How much cash does Intuitive Surgical have, and will it need more funding?
At December 31, 2002, cash, equivalents and short-term investments totaled $50.8M, down from $66.7M a year earlier. Intuitive has agreed to lend up to $7.3M to Computer Motion, and combined cash is projected below $35M at closing. Management believes resources will be sufficient through at least 2003, but says it may need to raise additional equity or debt afterward, which could dilute shareholders.
What are the biggest legal risks facing the company?
The most significant risk is the Computer Motion patent suit seeking damages, including possible treble damages, and potentially an injunction against da Vinci sales if the stay is lifted and Intuitive loses. The Brookhill-Wilk suit, on appeal before the Federal Circuit, carries similar exposure. Intuitive has favorable outcomes in some matters, including a $4.4M jury verdict against Computer Motion, but the company explicitly says it cannot predict the outcome of these matters or estimate possible losses.
Is the business growing, and what drives revenue?
Revenue is growing, but it is lumpy because each da Vinci system costs about $948K and sales cycles are long, requiring senior management approval. Management is shifting emphasis toward recurring revenue from EndoWrist instruments and service, which grew to 21% of 2002 sales. The company still posted operating losses in each quarter of 2002 and says profitability timing is highly uncertain.
04—Continue